Relationship between the initial dose of micafungin and its efficacy in patients with candidemia
- 1 January 2007
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 13 (4) , 208-212
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2004
- Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agentAlimentary Pharmacology & Therapeutics, 2004
- A Multicenter, Open-Label Clinical Study of Micafungin (FK463) in the Treatment of Deep-seated Mycosis in JapanScandinavian Journal of Infectious Diseases, 2004
- MicafunginDrugs, 2004
- Echinocandin antifungal drugsThe Lancet, 2003
- Caspofungin: the first in a new class of antifungal agentsDrug Resistance Updates, 2003
- The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacyExpert Opinion on Investigational Drugs, 2003
- Antifungal agents: mechanisms of actionTrends in Microbiology, 2003
- Comparison of Caspofungin and Amphotericin B for Invasive CandidiasisNew England Journal of Medicine, 2002